Kate Holt, Ph.D.
Senior Director, Investments
Kate Holt has acquired over eighteen years of executive-level experience forging innovative collaborations for the advancement of scientific discovery and translation of those discoveries into high impact deliverables. She has led business development and alliance management activities for multiple startup biotech companies including Lexicon Pharmaceuticals, Inc., KemPharm, Inc. and Memcine Pharmaceuticals. Kate has extensive experience in evaluating university IP and serving as a reviewer for competitive state funded commercialization grants. She currently serves as Senior Director of Investments and manages a portfolio of life sciences startup investments at the North Carolina Biotechnology Center.